Lahu G - Search Results

1

Single-dose pharmacokinetics of roflumilast in children and adolescents.

Neville KA, Szefler SJ, Abdel-Rahman SM, Lahu G, Zech K, Herzog R, Bethke TD, Gleason MC, Kearns GL. Neville KA, et al. Among authors: lahu g. J Clin Pharmacol. 2008 Aug;48(8):978-85. doi: 10.1177/0091270008319466. Epub 2008 May 28. J Clin Pharmacol. 2008. PMID: 18508947 Clinical Trial.

2

Effect of repeated dose of erythromycin on the pharmacokinetics of roflumilast and roflumilast N-oxide.

Lahu G, Huennemeyer A, Herzog R, McCracken N, Hermann R, Elmlinger M, Zech K. Lahu G, et al. Int J Clin Pharmacol Ther. 2009 Apr;47(4):236-45. doi: 10.5414/cpp47236. Int J Clin Pharmacol Ther. 2009. PMID: 19356389 Clinical Trial.

3

High absolute bioavailability of the new oral phosphodiesterase-4 inhibitor roflumilast.

Bethke TD, Lahu G. Bethke TD, et al. Among authors: lahu g. Int J Clin Pharmacol Ther. 2011 Jan;49(1):51-7. doi: 10.5414/cpp49051. Int J Clin Pharmacol Ther. 2011. PMID: 21176727 Clinical Trial.

4

Lack of pharmacokinetic and pharmacodynamic interactions of roflumilast with (R, S)-warfarin in healthy adult subjects.

McCracken N, Lahu G, Bethke TD. McCracken N, et al. Among authors: lahu g. Int J Clin Pharmacol Ther. 2011 Jun;49(6):388-96. doi: 10.5414/cp201523. Int J Clin Pharmacol Ther. 2011. PMID: 21612746 Clinical Trial.

5

Influence of renal impairment on the pharmacokinetics of oral roflumilast: an open-label, parallel-group, single-center study.

Bethke TD, Hartmann M, Hünnemeyer A, Lahu G, Gleiter CH. Bethke TD, et al. Among authors: lahu g. Int J Clin Pharmacol Ther. 2011 Aug;49(8):491-9. doi: 10.5414/cp201556. Int J Clin Pharmacol Ther. 2011. PMID: 21781649 Clinical Trial.

6

The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide.

Hermann R, Siegmund W, Giessmann T, Westphal K, Weinbrenner A, Hauns B, Reutter F, Lahu G, Zech K, Bethke TD. Hermann R, et al. Among authors: lahu g. J Clin Pharmacol. 2007 Aug;47(8):1005-13. doi: 10.1177/0091270007300950. J Clin Pharmacol. 2007. PMID: 17660483 Clinical Trial.

7

Effect of single and repeated doses of ketoconazole on the pharmacokinetics of roflumilast and roflumilast N-oxide.

Lahu G, Huennemeyer A, von Richter O, Hermann R, Herzog R, McCracken N, Zech K. Lahu G, et al. J Clin Pharmacol. 2008 Nov;48(11):1339-49. doi: 10.1177/0091270008321941. Epub 2008 Aug 29. J Clin Pharmacol. 2008. PMID: 18757786 Clinical Trial.

8

Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects.

Nassr N, Huennemeyer A, Herzog R, von Richter O, Hermann R, Koch M, Duffy K, Zech K, Lahu G. Nassr N, et al. Among authors: lahu g. Br J Clin Pharmacol. 2009 Oct;68(4):580-7. doi: 10.1111/j.1365-2125.2009.03478.x. Br J Clin Pharmacol. 2009. PMID: 19843061 Free PMC article.

9

Effect of steady-state enoxacin on single-dose pharmacokinetics of roflumilast and roflumilast N-oxide.

Lahu G, Nassr N, Herzog R, Elmlinger M, Ruth P, Hinder M, Huennemeyer A. Lahu G, et al. J Clin Pharmacol. 2011 Apr;51(4):586-93. doi: 10.1177/0091270010370590. Epub 2010 May 13. J Clin Pharmacol. 2011. PMID: 20466871 Clinical Trial.

10

Absence of pharmacokinetic interaction between roflumilast and digoxin in healthy adults.

Eckermann G, Lahu G, Nassr N, Bethke TD. Eckermann G, et al. Among authors: lahu g. J Clin Pharmacol. 2012 Feb;52(2):251-7. doi: 10.1177/0091270010389467. J Clin Pharmacol. 2012. PMID: 21257799 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters